Among the many comorbidities of patients affected by severe psoriasis, infections are very common. In particular hepatitis (expecially before the eradicatino) represented a great challange for the Dermatologist . Adalimumab has proven to be a safe option in this special group of patients.
Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature / Ricceri F.; Pescitelli L.; Lazzeri L.; Di Cesare A.; Prignano F.. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - ELETTRONICO. - 31:(2017), pp. e486-e486. [10.1111/jdv.14300]
Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature
Pescitelli L.;Prignano F.
2017
Abstract
Among the many comorbidities of patients affected by severe psoriasis, infections are very common. In particular hepatitis (expecially before the eradicatino) represented a great challange for the Dermatologist . Adalimumab has proven to be a safe option in this special group of patients.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
